Literature DB >> 3783826

Translational requirement of La Crosse virus S-mRNA synthesis: in vitro studies.

C Bellocq, R Raju, J Patterson, D Kolakofsky.   

Abstract

The exceptional requirement of La Crosse virus mRNA synthesis for ongoing protein synthesis in vivo was examined in vitro by using purified virions and a reticulocyte lysate. Transcription from the S genome produced two incomplete transcripts (110 and 205 nucleotides [nt]) in the absence of the lysate, whereas S-mRNA (900 nt) was predominantly made when the lysate was present. The addition of drugs which inhibit protein synthesis also inhibited the synthesis of S-mRNA, and in some cases led to the reappearance of the 205-nt RNA. Reconstruction experiments demonstrated that the incomplete transcripts were not the result of rapid and selective degradation of S-mRNA but were due to premature termination of the polymerase at defined sites. The requirement for ongoing protein synthesis for productive transcription in vitro is not at the level of chain initiation but for elongation of the nascent RNA beyond these sites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3783826      PMCID: PMC255209     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Identification of four complementary RNA species in Akabane virus-infected cells.

Authors:  A K Pattnaik; G Abraham
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

2.  Early RNA synthesis in Bunyamwera virus-infected cells.

Authors:  G Abraham; A K Pattnaik
Journal:  J Gen Virol       Date:  1983-06       Impact factor: 3.891

Review 3.  Priming of influenza viral RNA transcription by capped heterologous RNAs.

Authors:  R M Krug
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

4.  N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro.

Authors:  B M Blumberg; C Giorgi; D Kolakofsky
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

5.  Nonviral heterogeneous sequences are present at the 5' ends of one species of snowshoe hare bunyavirus S complementary RNA.

Authors:  D H Bishop; M E Gay; Y Matsuoko
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

6.  5'-Conformation of capped alfalfa mosaic virus ribonucleic acid 4 may reflect its independence of the cap structure or of cap-binding protein for efficient translation.

Authors:  L Gehrke; P E Auron; G J Quigley; A Rich; N Sonenberg
Journal:  Biochemistry       Date:  1983-10-25       Impact factor: 3.162

7.  Comparison of the sequences and coding of La Crosse and snowshoe hare bunyavirus S RNA species.

Authors:  H Akashi; D H Bishop
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

Review 8.  Attenuation in the control of expression of bacterial operons.

Authors:  C Yanofsky
Journal:  Nature       Date:  1981-02-26       Impact factor: 49.962

9.  Normal translation of human adenovirus mRNA in cell-free lysates prepared from abortively as well as productively infected monkey cells.

Authors:  M P Quinlan; D F Klessig
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  Characterization of La Crosse virus small-genome transcripts.

Authors:  J L Patterson; D Kolakofsky
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

View more
  17 in total

1.  Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

Authors:  John N Barr
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

2.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3.

Authors:  B P De; M S Galinski; A K Banerjee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Mechanism of La Crosse virus inhibition by ribavirin.

Authors:  L F Cassidy; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent.

Authors:  R Raju; L Raju; D Kolakofsky
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  La Crosse virus infection of mammalian cells induces mRNA instability.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Authors:  A Bridgen; F Weber; J K Fazakerley; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

8.  Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Translational requirement of La Crosse virus S-mRNA synthesis: in vivo studies.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

10.  Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction.

Authors:  R Fernandez-Larsson; K O'Connell; E Koumans; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.